CytomX Therapeutics, Inc. (FRA:6C1)
3.604
+0.032 (0.90%)
At close: Dec 1, 2025
279.37% (1Y)
| Market Cap | 625.40M |
| Revenue (ttm) | 96.85M |
| Net Income (ttm) | 23.88M |
| Shares Out | n/a |
| EPS (ttm) | 0.20 |
| PE Ratio | 26.19 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 831 |
| Open | 3.604 |
| Previous Close | 3.572 |
| Day's Range | 3.604 - 3.604 |
| 52-Week Range | 0.384 - 3.822 |
| Beta | n/a |
| RSI | 62.24 |
| Earnings Date | Mar 6, 2026 |